Oncolytic myxoma virus: The path to clinic
Oncolytic myxoma virus: The path to clinic
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights•MYXV is a candidate oncolytic virus with varying efficacies of oncolytic properties. •MYXV productively infects many classes of human cancer cells. •MYXV discriminates cancerous human myeloid cells from the normal CD34 + stem cells. •MYXV is an attractive ex vivo purging agent candidate for hematological malignancies. •MYXV possesses sig...
Alternative Titles
Full title
Oncolytic myxoma virus: The path to clinic
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3755036
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3755036
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2013.05.056
